Peer-influenced content. Sources you trust. No registration required. This is HCN.
Conexiant
Breast cancer screening remains a persistent area of variation in clinical practice. Updated guidance from the American College of Physicians aims to clarify when screening offers meaningful benefit for average‑risk patients — and when it may not.
Internal Medicine April 22nd 2026
Annals of Internal Medicine
Despite the scale of prostate-specific antigen (PSA) testing for prostate cancer screening, prediction models do not predict time-to-event end points or adjust for patient life expectancy.
Family Medicine/General Practice February 6th 2026